HIV-1 control program fails in Zimbabwe

A trial in Zimbabwe has shown that a programme of integrated peer education, condom distribution, and management of sexually transmitted infections did not reduce the overall incidence of HIV-1.

The study, published in PLoS Medicine, by Simon Gregson and colleagues from Imperial College London, randomised different communities in eastern Zimbabwe over a 3 year period. Six pairs of communities in Eastern Zimbabwe were compared, each of which had its own health center. Control communities received the standard government services for preventing HIV. The other communities received a package of additional strategies including education and condom distribution amongst sex workers and their clients; better services at sexually transmitted infection clinics; and educational HIV/AIDS open days at health centers. This was a large trial with more than 63,000 meetings being conducted and 7 million condoms distributed by trained peer educators. The researchers found that although male participants benefit ed from the programme with a decrease in incidence of HIV-1, a reduction in reporting of unprotected sex with casual partners, and a decrease in symptoms of sexually transmitted infections, overall there was no change in any of these outcomes for the population at large including the incidence of HIV-1 among the population in general - the main outcome of the trial.

These results are disappointing given the urgent need for control measures for HIV-1 in sub-Saharan Africa. The authors conclude that they "emphasise the need for alternative strategies of behaviour-change promotion."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows safety of kidney transplants among those with HIV infections